IPOsBy The Online Investor Staff, updated Mon., Feb. 18, 3:39 PM
|This Slide: #1 of 15|
Slide #1. Hoth Therapeutics Inc — Initial Public Offering
Hoth Therapeutics Inc
Price Per Share:
Hoth Therapeutics Inc. ("Hoth" or the "Company"), a development stage biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications such as atopic dermatitis, also known as eczema, today announced the pricing of its initial public offering of 1,250,000 shares of its common stock at an initial offering price to the public of $5.60 per share. All shares of common stock are being offered by Hoth. In addition, Hoth has granted the underwriters a 30-day option to purchase up to an additional 187,500 shares of common stock at the initial public offering price, less the underwriting discount, to cover over-allotments, if any.